{"entity":{"type":"insider","cik":"0001479386","url":"/insider/0001479386","json_url":"/insider/0001479386.json","name":"Viswanathan Ravi","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":83,"n_filings":48,"first":"2011-11-22","last":"2018-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Viswanathan Ravi","source":"filing","n_filings":48,"first_seen":"2011-11-22","last_seen":"2018-10-24"}],"transactions":[{"id":6156574,"accession":"0001209191-18-056072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-056072","line_url":"/filing/0001209191-18-056072#line-2","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KERINS PATRICK J; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP; BARRIS PETER J; SANDELL SCOTT D; NEA Partners 13, Limited Partnership; BASKETT FOREST; BARRETT M JAMES; Viswanathan Ravi; MOTT DAVID M","owner_display_name":"KERINS PATRICK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800000.0,"shares_display":"1,800,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":9000000.0,"total_display":"9,000,000.00","total_whole":"9,000,000","shares_owned_after":6641634.0,"shares_owned_after_display":"6,641,634","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-22","filed_date":"2018-10-24","scope":"insider"},{"id":6369783,"accession":"0001209191-18-050293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-050293","line_url":"/filing/0001209191-18-050293","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares with a nominal value of 0.001 GBP per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000000.0,"shares_display":"15,000,000","price_per_share":1.6667,"price_display":"1.67","price_state":"stated","total_value":25000500.0,"total_display":"25,000,500.00","total_whole":"25,000,500","shares_owned_after":12000000.0,"shares_owned_after_display":"12,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-07","filed_date":"2018-09-10","scope":"insider","n_lines":2},{"id":6267274,"accession":"0001209191-18-047972","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-047972","line_url":"/filing/0001209191-18-047972#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":663716.0,"shares_display":"663,716","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":1499998.16,"total_display":"1,499,998.16","total_whole":"1,499,998","shares_owned_after":18698038.0,"shares_owned_after_display":"18,698,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-21","filed_date":"2018-08-22","scope":"insider"},{"id":6706984,"accession":"0001209191-18-043489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-043489","line_url":"/filing/0001209191-18-043489#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50600.0,"shares_display":"50,600","price_per_share":1.9993,"price_display":"2.00","price_state":"stated","total_value":101164.58,"total_display":"101,164.58","total_whole":"101,165","shares_owned_after":18034322.0,"shares_owned_after_display":"18,034,322","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-19","filed_date":"2018-07-20","scope":"insider"},{"id":6706980,"accession":"0001209191-18-043489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-043489","line_url":"/filing/0001209191-18-043489#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.9529,"price_display":"1.95","price_state":"stated","total_value":390580.0,"total_display":"390,580.00","total_whole":"390,580","shares_owned_after":17983722.0,"shares_owned_after_display":"17,983,722","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-18","filed_date":"2018-07-20","scope":"insider"},{"id":6292074,"accession":"0001209191-18-039969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-039969","line_url":"/filing/0001209191-18-039969#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187130.0,"shares_display":"187,130","price_per_share":2.0985,"price_display":"2.10","price_state":"stated","total_value":392692.305,"total_display":"392,692.30","total_whole":"392,692","shares_owned_after":17783722.0,"shares_owned_after_display":"17,783,722","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-28","filed_date":"2018-06-28","scope":"insider"},{"id":6292070,"accession":"0001209191-18-039969","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-039969","line_url":"/filing/0001209191-18-039969#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5295.0,"shares_display":"5,295","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":11384.25,"total_display":"11,384.25","total_whole":"11,384","shares_owned_after":17596592.0,"shares_owned_after_display":"17,596,592","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2018-06-28","scope":"insider"},{"id":6706326,"accession":"0001209191-18-034194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-034194","line_url":"/filing/0001209191-18-034194#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275.0,"shares_display":"275","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":591.25,"total_display":"591.25","total_whole":"591","shares_owned_after":17591297.0,"shares_owned_after_display":"17,591,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider"},{"id":6421952,"accession":"0001209191-18-031990","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-031990","line_url":"/filing/0001209191-18-031990#line-3","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32200.0,"shares_display":"32,200","price_per_share":2.1447,"price_display":"2.14","price_state":"stated","total_value":69059.34,"total_display":"69,059.34","total_whole":"69,059","shares_owned_after":17591022.0,"shares_owned_after_display":"17,591,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-21","filed_date":"2018-05-21","scope":"insider"},{"id":6421949,"accession":"0001209191-18-031990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-031990","line_url":"/filing/0001209191-18-031990#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20100.0,"shares_display":"20,100","price_per_share":2.1357,"price_display":"2.14","price_state":"stated","total_value":42927.57,"total_display":"42,927.57","total_whole":"42,928","shares_owned_after":17558822.0,"shares_owned_after_display":"17,558,822","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-21","scope":"insider"},{"id":6421946,"accession":"0001209191-18-031990","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-031990","line_url":"/filing/0001209191-18-031990#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":184179.0,"shares_display":"184,179","price_per_share":2.1253,"price_display":"2.13","price_state":"stated","total_value":391435.6287,"total_display":"391,435.63","total_whole":"391,436","shares_owned_after":17538722.0,"shares_owned_after_display":"17,538,722","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-21","scope":"insider"},{"id":5961373,"accession":"0001209191-18-029305","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-029305","line_url":"/filing/0001209191-18-029305#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70873.0,"shares_display":"70,873","price_per_share":2.1341,"price_display":"2.13","price_state":"stated","total_value":151250.0693,"total_display":"151,250.07","total_whole":"151,250","shares_owned_after":17354543.0,"shares_owned_after_display":"17,354,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-08","filed_date":"2018-05-10","scope":"insider"},{"id":6043442,"accession":"0001209191-18-025852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-025852","line_url":"/filing/0001209191-18-025852#line-2","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133333.0,"shares_display":"133,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1999995.0,"total_display":"1,999,995.00","total_whole":"1,999,995","shares_owned_after":3312877.0,"shares_owned_after_display":"3,312,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-23","scope":"insider"},{"id":6133500,"accession":"0001209191-18-024543","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-024543","line_url":"/filing/0001209191-18-024543#line-3","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":203200.0,"shares_display":"203,200","price_per_share":2.4606,"price_display":"2.46","price_state":"stated","total_value":499993.92,"total_display":"499,993.92","total_whole":"499,994","shares_owned_after":17283670.0,"shares_owned_after_display":"17,283,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-10","filed_date":"2018-04-10","scope":"insider"},{"id":6133496,"accession":"0001209191-18-024543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-024543","line_url":"/filing/0001209191-18-024543#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32100.0,"shares_display":"32,100","price_per_share":2.433,"price_display":"2.43","price_state":"stated","total_value":78099.3,"total_display":"78,099.30","total_whole":"78,099","shares_owned_after":17080470.0,"shares_owned_after_display":"17,080,470","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-09","filed_date":"2018-04-10","scope":"insider"},{"id":6133493,"accession":"0001209191-18-024543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-024543","line_url":"/filing/0001209191-18-024543#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":685676.0,"shares_display":"685,676","price_per_share":2.2415,"price_display":"2.24","price_state":"stated","total_value":1536942.754,"total_display":"1,536,942.75","total_whole":"1,536,943","shares_owned_after":17048370.0,"shares_owned_after_display":"17,048,370","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-06","filed_date":"2018-04-10","scope":"insider"},{"id":6518724,"accession":"0001209191-18-021947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-021947","line_url":"/filing/0001209191-18-021947#line-2","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares with a nominal value of 0.001 GBP per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000000.0,"shares_display":"6,000,000","price_per_share":1.9167,"price_display":"1.92","price_state":"stated","total_value":11500200.0,"total_display":"11,500,200.00","total_whole":"11,500,200","shares_owned_after":79978672.0,"shares_owned_after_display":"79,978,672","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-27","filed_date":"2018-03-28","scope":"insider"},{"id":6453728,"accession":"0001209191-18-021756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021756","line_url":"/filing/0001209191-18-021756#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Viswanathan Ravi; NEA 14 GP, LTD; NEA Partners 14, L.P.","owner_display_name":"Viswanathan Ravi","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":707964.0,"shares_display":"707,964","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":1911502.8,"total_display":"1,911,502.80","total_whole":"1,911,503","shares_owned_after":3466003.0,"shares_owned_after_display":"3,466,003","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-27","filed_date":"2018-03-27","scope":"insider"},{"id":6518721,"accession":"0001209191-18-021947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021947","line_url":"/filing/0001209191-18-021947#line-1","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares with a nominal value of 0.001 GBP per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":571164.0,"shares_display":"571,164","price_per_share":1.9041,"price_display":"1.90","price_state":"stated","total_value":1087553.3724,"total_display":"1,087,553.37","total_whole":"1,087,553","shares_owned_after":73978672.0,"shares_owned_after_display":"73,978,672","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-26","filed_date":"2018-03-28","scope":"insider"},{"id":6075971,"accession":"0001209191-18-021553","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-021553","line_url":"/filing/0001209191-18-021553#line-3","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares with a nominal value of 0.001 GBP per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":294090.0,"shares_display":"294,090","price_per_share":1.9462,"price_display":"1.95","price_state":"stated","total_value":572357.958,"total_display":"572,357.96","total_whole":"572,358","shares_owned_after":73407508.0,"shares_owned_after_display":"73,407,508","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-23","filed_date":"2018-03-23","scope":"insider"},{"id":6075968,"accession":"0001209191-18-021553","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-021553","line_url":"/filing/0001209191-18-021553#line-2","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares with a nominal value of 0.001 GBP per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":869574.0,"shares_display":"869,574","price_per_share":1.904,"price_display":"1.90","price_state":"stated","total_value":1655668.896,"total_display":"1,655,668.90","total_whole":"1,655,669","shares_owned_after":73113418.0,"shares_owned_after_display":"73,113,418","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-22","filed_date":"2018-03-23","scope":"insider"},{"id":6075966,"accession":"0001209191-18-021553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021553","line_url":"/filing/0001209191-18-021553#line-1","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares with a nominal value of 0.001 GBP per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":104844.0,"shares_display":"104,844","price_per_share":1.8105,"price_display":"1.81","price_state":"stated","total_value":189820.062,"total_display":"189,820.06","total_whole":"189,820","shares_owned_after":72243844.0,"shares_owned_after_display":"72,243,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-21","filed_date":"2018-03-23","scope":"insider"},{"id":6043009,"accession":"0001209191-18-017559","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-18-017559","line_url":"/filing/0001209191-18-017559","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15793.0,"shares_display":"15,793","price_per_share":59.8154,"price_display":"59.82","price_state":"stated","total_value":944664.6122,"total_display":"944,664.61","total_whole":"944,665","shares_owned_after":9681129.0,"shares_owned_after_display":"9,681,129","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-06","scope":"insider","n_lines":2},{"id":6043004,"accession":"0001209191-18-017559","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-18-017559","line_url":"/filing/0001209191-18-017559","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61437.0,"shares_display":"61,437","price_per_share":58.8299403421391,"price_display":"58.83","price_state":"stated","total_value":3614335.0448,"total_display":"3,614,335.04","total_whole":"3,614,335","shares_owned_after":9649647.0,"shares_owned_after_display":"9,649,647","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-06","scope":"insider","n_lines":6},{"id":6042990,"accession":"0001209191-18-017559","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-017559","line_url":"/filing/0001209191-18-017559","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68302.0,"shares_display":"68,302","price_per_share":55.564763880999095,"price_display":"55.56","price_state":"stated","total_value":3795184.5026,"total_display":"3,795,184.50","total_whole":"3,795,185","shares_owned_after":9590988.0,"shares_owned_after_display":"9,590,988","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-02","filed_date":"2018-03-06","scope":"insider","n_lines":8},{"id":6603655,"accession":"0001209191-18-013942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-013942","line_url":"/filing/0001209191-18-013942#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1460209.0,"shares_display":"1,460,209","price_per_share":0.5008,"price_display":"0.50","price_state":"stated","total_value":731272.6672,"total_display":"731,272.67","total_whole":"731,273","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-27","scope":"insider"},{"id":5959880,"accession":"0001209191-18-011903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-011903","line_url":"/filing/0001209191-18-011903#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"MOTT DAVID M; NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd; BARRETT M JAMES; NEA Partners 13, Limited Partnership; KERINS PATRICK J; BASKETT FOREST; Viswanathan Ravi; BARRIS PETER J; SANDELL SCOTT D","owner_display_name":"MOTT DAVID M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":12000000.0,"total_display":"12,000,000.00","total_whole":"12,000,000","shares_owned_after":5490073.0,"shares_owned_after_display":"5,490,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-21","scope":"insider"},{"id":4198633,"accession":"0001209191-17-062624","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-062624","line_url":"/filing/0001209191-17-062624#line-2","is_derivative":false,"issuer_cik":"0001441683","issuer_name":"APPIAN CORP","issuer_ticker":"APPN","issuer_name_source":null,"issuer_url":"/issuer/0001441683","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":569620.0,"shares_display":"569,620","price_per_share":19.49,"price_display":"19.49","price_state":"stated","total_value":11101893.8,"total_display":"11,101,893.80","total_whole":"11,101,894","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-27","filed_date":"2017-11-27","scope":"insider"},{"id":4662092,"accession":"0001209191-17-062096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-062096","line_url":"/filing/0001209191-17-062096#line-2","is_derivative":false,"issuer_cik":"0001441683","issuer_name":"APPIAN CORP","issuer_ticker":"APPN","issuer_name_source":null,"issuer_url":"/issuer/0001441683","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2820516.0,"shares_display":"2,820,516","price_per_share":19.49,"price_display":"19.49","price_state":"stated","total_value":54971856.84,"total_display":"54,971,856.84","total_whole":"54,971,857","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-20","filed_date":"2017-11-21","scope":"insider"},{"id":4630576,"accession":"0001209191-17-056471","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-056471","line_url":"/filing/0001209191-17-056471#line-3","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":9350000.0,"total_display":"9,350,000.00","total_whole":"9,350,000","shares_owned_after":4909956.0,"shares_owned_after_display":"4,909,956","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-10","scope":"insider"},{"id":4488528,"accession":"0001209191-17-044157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-044157","line_url":"/filing/0001209191-17-044157#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":8140138.0,"shares_owned_after_display":"8,140,138","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-06","scope":"insider"},{"id":4738821,"accession":"0001209191-17-023496","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-023496","line_url":"/filing/0001209191-17-023496#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000000.0,"shares_display":"6,000,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":16362694.0,"shares_owned_after_display":"16,362,694","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-28","filed_date":"2017-03-29","scope":"insider"},{"id":4357095,"accession":"0001209191-17-023150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-023150","line_url":"/filing/0001209191-17-023150#line-1","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares with a nominal value of 0.001 GBP per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12870000.0,"shares_display":"12,870,000","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":9009000.0,"total_display":"9,009,000.00","total_whole":"9,009,000","shares_owned_after":72139000.0,"shares_owned_after_display":"72,139,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-27","filed_date":"2017-03-28","scope":"insider"},{"id":3357768,"accession":"0001209191-16-155952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-155952","line_url":"/filing/0001209191-16-155952#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":6750000.0,"total_display":"6,750,000.00","total_whole":"6,750,000","shares_owned_after":5215128.0,"shares_owned_after_display":"5,215,128","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-19","filed_date":"2016-12-19","scope":"insider"},{"id":2747164,"accession":"0001209191-16-152343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-152343","line_url":"/filing/0001209191-16-152343#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":869565.0,"shares_display":"869,565","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":4999998.75,"total_display":"4,999,998.75","total_whole":"4,999,999","shares_owned_after":2758039.0,"shares_owned_after_display":"2,758,039","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-11-29","scope":"insider"},{"id":2968167,"accession":"0001209191-16-147490","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-147490","line_url":"/filing/0001209191-16-147490#line-5","is_derivative":false,"issuer_cik":"0001479386","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001479386","owner_cik":"0001479386","owner_name":"Viswanathan Ravi","owner_display_name":"Viswanathan Ravi","owner_url":"/insider/0001479386","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":435.0,"shares_display":"435","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5655.0,"total_display":"5,655.00","total_whole":"5,655","shares_owned_after":80223.0,"shares_owned_after_display":"80,223","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-10-31","scope":"insider"}],"collapsed":true,"next_cursor":"2016-10-31|2968167","ledger_fault":false,"count":{"value":79,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":67,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":79},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001169245","name":"PhaseBio Pharmaceuticals Inc","url":"/issuer/0001169245","role":"Ten percent owner","n_filings":1,"first_seen":"2018-10-24","last_seen":"2018-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001621227","name":"Adaptimmune Therapeutics PLC","url":"/issuer/0001621227","role":"Ten percent owner","n_filings":4,"first_seen":"2017-03-28","last_seen":"2018-09-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS INC","url":"/issuer/0001325879","role":"Ten percent owner","n_filings":8,"first_seen":"2017-03-29","last_seen":"2018-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001718108","name":"Surface Oncology, Inc.","url":"/issuer/0001718108","role":"Ten percent owner","n_filings":1,"first_seen":"2018-04-23","last_seen":"2018-04-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001394319","name":"Tracon Pharmaceuticals, Inc.","url":"/issuer/0001394319","role":"Ten percent owner","n_filings":3,"first_seen":"2015-02-05","last_seen":"2018-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001491576","name":"TESARO, Inc.","url":"/issuer/0001491576","role":"Ten percent owner","n_filings":4,"first_seen":"2012-07-03","last_seen":"2018-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"ARCA biopharma, Inc.","url":"/issuer/0000907654","role":"Ten percent owner","n_filings":1,"first_seen":"2018-02-27","last_seen":"2018-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Ten percent owner","n_filings":2,"first_seen":"2016-10-31","last_seen":"2018-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001441683","name":"APPIAN CORP","url":"/issuer/0001441683","role":"Ten percent owner","n_filings":2,"first_seen":"2017-11-21","last_seen":"2017-11-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Ten percent owner","n_filings":1,"first_seen":"2017-10-10","last_seen":"2017-10-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001442836","name":"Mersana Therapeutics, Inc.","url":"/issuer/0001442836","role":"Ten percent owner","n_filings":1,"first_seen":"2017-07-06","last_seen":"2017-07-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001301501","name":"Achaogen Inc","url":"/issuer/0001301501","role":"Ten percent owner","n_filings":1,"first_seen":"2016-12-19","last_seen":"2016-12-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001037649","name":"INTERLEUKIN GENETICS INC","url":"/issuer/0001037649","role":"Ten percent owner","n_filings":2,"first_seen":"2014-12-29","last_seen":"2016-08-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001437402","name":"ARDELYX, INC.","url":"/issuer/0001437402","role":"Ten percent owner","n_filings":2,"first_seen":"2016-01-14","last_seen":"2016-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Ten percent owner","n_filings":4,"first_seen":"2013-06-07","last_seen":"2016-01-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001527599","name":"Mirna Therapeutics, Inc.","url":"/issuer/0001527599","role":"Ten percent owner","n_filings":1,"first_seen":"2015-10-06","last_seen":"2015-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001557883","name":"Dermira, Inc.","url":"/issuer/0001557883","role":"Ten percent owner","n_filings":1,"first_seen":"2014-10-08","last_seen":"2014-10-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001122897","name":"CVENT INC","url":"/issuer/0001122897","role":"Ten percent owner","n_filings":3,"first_seen":"2014-01-21","last_seen":"2014-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001581720","name":"Loxo Oncology, Inc.","url":"/issuer/0001581720","role":"Ten percent owner","n_filings":1,"first_seen":"2014-08-06","last_seen":"2014-08-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001472343","name":"Roka BioScience, Inc.","url":"/issuer/0001472343","role":"Ten percent owner","n_filings":1,"first_seen":"2014-07-22","last_seen":"2014-07-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"GLYCOMIMETICS INC","url":"/issuer/0001253689","role":"Ten percent owner","n_filings":1,"first_seen":"2014-01-15","last_seen":"2014-01-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001477598","name":"Omthera Pharmaceuticals, Inc.","url":"/issuer/0001477598","role":"Ten percent owner","n_filings":1,"first_seen":"2013-04-17","last_seen":"2013-04-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001372375","name":"Millennial Media Inc.","url":"/issuer/0001372375","role":"Ten percent owner","n_filings":1,"first_seen":"2012-10-30","last_seen":"2012-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Ten percent owner","n_filings":1,"first_seen":"2011-11-22","last_seen":"2011-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001479386","retrieved_at":"2026-08-25T01:26:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}